Company Spotlight / JLABS @ Shanghai
Johnson & Johnson’s network of healthcare innovation incubators, JLABS, opened its doors in Shanghai in June…
Patrick Burton |
Editor
Patrick is an editor at PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 30 country reports and is a fluent Mandarin speaker.
Articles: Patrick Burton
European Pharma Mid-Caps’ US Strategies / Complexity, Scale, Talent
Three US country managers for European pharma mid-caps explain the challenges in setting up an American affiliate,…
Pfizer / A Unique COVID-19 Vaccine Approach
At the 28 May 2020 IFPMA media briefing on COVID-19 vaccines, Pfizer chairman and CEO Dr Albert Bourla outlined why…
COVID-19 Vaccines / AstraZeneca, GSK, J&J & Pfizer Execs’ Key Concerns
During the 28 May 2020 IFPMA media briefing on COVID-19 vaccines, four of the pharmaceutical industry’s leading…
Oncology in Morocco / Access Challenges & New Solutions
Morocco has made admirable progress in building a national oncology network in recent years, but the country’s…
Pharma Faces / Taher Hassen, Merck Morocco
Taher Hassen has been in position as GM for Morocco and Tunisia at Merck for four years, overseeing year-on-year…
Company Spotlight / Iberma
Iberma, one of the leading domestic pharma manufacturers in Morocco, has evolved significantly since its founding…
Pharma Faces / Jorge Alderete, ALK Americas
Jorge Alderete, president of ALK Americas, recently spoke to PharmaBoardroom about his 20+ years with the Danish…
Words of Wisdom / Women in Pharma
Four Belgium country managers for some of the world’s largest pharma companies give their words of wisdom for…
Pharma Faces / Carol Lynch, Sandoz US
Carol Lynch, president of Sandoz US and head of Sandoz North America, recently spoke exclusively to PharmaBoardroom…
Chinese Biotech / Domestic Pricing Strategies
Alphamab Oncology and I-Mab Biopharma, two of China’s fastest-growing biotech firms, both bolstered by recent…
Novartis Oncology / CAR-T’s Journey to Market in Europe
Two years on from the introduction of Novartis Oncology’s CAR-T therapy to Europe, Emnuele Ostuni, the firm’s…